Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
ZERBAXA 1.5 g Trockensub 1000 mg 10 Stk
Drug
Zerbaxa, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Infektionskrankheiten
08.01.3. – cephalosporins
HAM – Human medicine
PULPA – Powder for parenteral solution
S – synthetic products for human use
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
3/3/2016
12/31/9999
Dosage strength
Zerbaxa 1.5 g, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Infektionskrankheiten
01
Z – approved
Package
7680654720016
In trade from / since 3/3/2016
A/R – Authorised / referenced
10 vial(s)
001
Z – approved
Declaration
Component Dry preparation
1000 mg ceftolozanum
ceftolozani sulfas
500 mg tazobactamum
tazobactamum natricum
ceftolozani sulfas
500 mg tazobactamum
tazobactamum natricum
acidum citricum
natrii chloridum
argininum
230 mg natrium
natrii chloridum
argininum
230 mg natrium
Authorisation holder
7601001001138
MSD Merck Sharp & Dohme AG
Werftestrasse 4
6005 Luzern (LU)
Werftestrasse 4
6005 Luzern (LU)
Date of revision of the text
9/17/2025
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.